Novo Nordisk Once Again Struggling with a Fire. According to the company, a fire broke out in front of a building at the company headquarters in the Copenhagen suburb of Bagsvaerd, which has spread to an adjacent office building. Already last Thursday, a building under construction at the production site in Kalundborg burned, where the company is currently expanding its capacity for the highly sought-after diabetes and weight loss medications.

"The fire brigade is present, and the extinguishing is expected to take several hours," Novo Nordisk stated regarding the fire on Wednesday. The smoke is not toxic and there are no reports of injuries.

The Novo Nordisk stock reacted to the news with a temporary decline of 1.13 percent and was listed at the Copenhagen Stock Exchange at 916.70 Danish Kroner.

These Fires Come At A Critical Time For The Company, Which Is A Global Leader In The Production Of Diabetes And Weight Loss Medications. The Demand For These Medicines Has Increased Significantly In Recent Years, Prompting Novo Nordisk To Substantially Expand Its Production Capacities.

Despite the Recent Incidents, the Company Remains Optimistic that Production and Capacity Expansion Can Continue as Planned. In a Statement, Novo Nordisk Emphasized that the Safety of Employees and the Minimization of Operational Disruptions are of the Utmost Priority.

The exact cause of the fires is currently under investigation, and the fire department is expected to be busy with extinguishing efforts for several hours more.